BioTech
How to make the EU’s new Joint Clinical Assessment process work for industry — and for patients
Today, the criteria used to assess the clinical value of new pharmaceuticals and medical devices varies widely across Europe, making it more challenging for biopharma
Tommy Bramley and Herbert Altmann and Casper Paardekooper
October 20, 2023